High-volume antibody testing platform could accelerate disease research and treatment development
Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but studying them is slow, expensive and labor-intensive. Now, researchers at the University of Illinois ...
Sep 3, 2025
0
14









